Business

Merck in talks to buy cancer drugmaker Revolution Medicines for up to $32bn

US company is attempting to acquire the maker of a new treatment for pancreatic cancer

Economist AdminEconomist Admin
Merck in talks to buy cancer drugmaker Revolution Medicines for up to $32bn
US company is attempting to acquire the maker of a new treatment for pancreatic cancer
Read More

Tags:

Previous Article

Venezuela says it will release an ‘important number’ of prisoners

Next Article

Glencore and Rio Tinto resume talks on $260bn mining megadeal

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Economist Admin
Economist Admin Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.

Related Posts

Dubai Shopping Festival announces discounts up to 90%, 12-hour sale

Dubai Shopping Festival announces discounts up to 90%, ...

Economist Admin

Blinkit Drops 10-Minute Promise: India’s Quick Commerce Shifts Focus to Rider Safety

Blinkit Drops 10-Minute Promise: India’s Quick Commerce...

Economist Admin

Tata Power acquires 40% stake in Bhutan's Khorlochhu hydro project for ₹830 crore

Tata Power acquires 40% stake in Bhutan's Khorlochhu hy...

FEDA-HQ